Shane S Neibart1, Sharon L Manne2, Salma K Jabbour1. 1. Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, United States. 2. Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, United States.
Abstract
PURPOSE OF REVIEW: With advances in radiation therapy (RT) techniques for rectal and anal cancers allowing for the modulation of critical normal tissues, there has been an increased emphasis on improving the quality of life (QOL) of cancer survivors. Herein, we review the literature to examine the impact of RT on QOL and patient reported outcomes (PROs) to better inform providers about the challenges of survivorship. RECENT FINDINGS: Large systematic reviews, recent studies and long-term follow-up of pivotal clinical trials have shown that RT impacts QOL, particularly fecal continence and sexual function. Modern preoperative RT techniques allow for decreased dose to organs-at-risk will likely improve QOL. SUMMARY: RT, though critical in the treatment of rectal and anal cancer, has a profound impact on QOL for some patients. Recent studies have included PROs and validated QOL metrics to better inform providers and patients.
PURPOSE OF REVIEW: With advances in radiation therapy (RT) techniques for rectal and anal cancers allowing for the modulation of critical normal tissues, there has been an increased emphasis on improving the quality of life (QOL) of cancer survivors. Herein, we review the literature to examine the impact of RT on QOL and patient reported outcomes (PROs) to better inform providers about the challenges of survivorship. RECENT FINDINGS: Large systematic reviews, recent studies and long-term follow-up of pivotal clinical trials have shown that RT impacts QOL, particularly fecal continence and sexual function. Modern preoperative RT techniques allow for decreased dose to organs-at-risk will likely improve QOL. SUMMARY: RT, though critical in the treatment of rectal and anal cancer, has a profound impact on QOL for some patients. Recent studies have included PROs and validated QOL metrics to better inform providers and patients.
Entities:
Keywords:
Anus Neoplasms; Cancer Survivors; Patient Reported Outcome Measures; Quality of Life; Radiation Therapy; Rectal Neoplasms
Authors: Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab Journal: N Engl J Med Date: 2004-10-21 Impact factor: 91.245
Authors: Anne Gry Bentzen; Lise Balteskard; Eva Hoff Wanderås; Gunilla Frykholm; Tom Wilsgaard; Olav Dahl; Marianne Grønlie Guren Journal: Acta Oncol Date: 2013-02-26 Impact factor: 4.089
Authors: Arwen H Pieterse; Marleen Kunneman; Wilbert B van den Hout; Monique Baas-Thijssen; Elisabeth D Geijsen; Heleen M Ceha; Karin M Muller; Yvette M van der Linden; Corrie A M Marijnen; Anne M Stiggelbout Journal: Acta Oncol Date: 2019-04-11 Impact factor: 4.089
Authors: Corrie A M Marijnen; Cornelis J H van de Velde; Hein Putter; Mandy van den Brink; Cornelis P Maas; Hendrik Martijn; Harm J Rutten; Theo Wiggers; Elma Klein Kranenbarg; Jan-Willem H Leer; Anne M Stiggelbout Journal: J Clin Oncol Date: 2005-03-20 Impact factor: 44.544
Authors: Lisette M Wiltink; Remi A Nout; Jochem R N van der Voort van Zyp; Heleen M Ceha; Marta Fiocco; Elma Meershoek-Klein Kranenbarg; Andreas W K S Marinelli; Cornelis J H van de Velde; Corrie A M Marijnen Journal: Clin Colorectal Cancer Date: 2016-02-13 Impact factor: 4.481
Authors: Krishan R Jethwa; Courtney N Day; Harigopal Sandhyavenu; Karthik Gonuguntla; William S Harmsen; William G Breen; David M Routman; Allison E Garda; Joleen M Hubbard; Thorvardur R Halfdanarson; Michelle A Neben-Wittich; Kenneth W Merrell; Christopher L Hallemeier; Michael G Haddock Journal: Clin Transl Radiat Oncol Date: 2021-02-23